Intramolecular Pd(II)-Catalyzed Cyclization of Propargylamides: Straightforward Synthesis of 5-Oxazole-carbaldehydes by BECCALLI E. M et al.
Intramolecular Pd(II)-Catalyzed Cyclization of Propargylamides: 
Straightforward Synthesis of 5-oxazole-carbaldehydes 
Journal: The Journal of Organic Chemistry 
Manuscript ID: jo-2008-00621n.R1 
Manuscript Type: Note 
Date Submitted by the 
Author:
11-Apr-2008 
Complete List of Authors: Beccalli, Egle Maria; University of Milan, Istituto di Chimica 
Organica "A. Marchesini" 
Borsini, Elena; Università degli Studi dell'Insubria, Dipartimento di 
Scienze Chimiche ed Ambientali 
Broggini, Gianluigi; Università dell'Insubria, Dipartimento di Scienze 
Chimiche e Ambientali 
Palmisano, Giovanni; Università degli Studi dell'Insubria, 
Dipartimento di Scienze Chimiche ed Ambientali 
Sottocornola, Silvia; Università degli Studi dell'Insubria, 
Dipartimento di Scienze Chimiche ed Ambientali 
ACS Paragon Plus Environment
Submitted to The Journal of Organic Chemistry
1Intramolecular Pd(II)-Catalyzed Cyclization of 
Propargylamides: Straightforward Synthesis of 5-
Oxazole-carbaldehydes
Egle M. Beccalli,§ Elena Borsini,# Gianluigi Broggini,*#
Giovanni Palmisano,# Silvia Sottocornola#
Istituto di Chimica Organica “A. Marchesini”, Facoltà di 
Farmacia, Università di Milano, via Venezian 21, 20133 
Milano, Italy, and Dipartimento di Scienze Chimiche e 
Ambientali, Università dell’Insubria, via Valleggio 11, 22100 
Como, Italy
gianluigi.broggini@uninsubria.it
RECEIVED DATE (will be automatically inserted after 
manuscript is accepted).
Direct synthesis of 2-substituted 5-oxazole-carbaldehydes 
was performed by intramolecular reaction of 
propargylamides through treatment with catalytic amount of 
Pd(II) salts in the presence of stoichiometric amount of 
reoxidant agent. The heterocyclization process was well 
tolerated by a wide range of aryl, heteroaryl and alkyl 
propargylamides. This protocol constitutes a valuable 
synthetic way to 5-oxazole-carbaldehydes, alternative to the 
formylation on oxazole rings, often unsatisfactory in term 
of regioselectivity and yields.
Intramolecular palladium-promoted cyclizations are became 
a milestone also in heterocyclic synthesis.1 A widespread array 
of hetero(poly)cycles have been achieved by different 
methodologies using catalytic amount of palladium.2 Among 
the most used reaction typologies, including the well-known 
Heck, Buchwald-Hartwig, and cross-coupling reactions, the 
Pd(II)-catalyzed oxidative reactions (i.e. Wacker-type 
reactions) play a prominent role due to the simplified 
requirements of the starting material.3,4
Our previous contribution in this area was concerned with 
intramolecular cyclizations of alkenyl systems bearing a 
nucleophilic moiety under conditions which require Pd(II)-
catalysis in the presence of stoichiometric amount of an 
oxidant agent.5 In particular, we recently found that N-allyl 1-
allyl-2-indolecarboxyamide 1 undergoes an intramolecular 
Pd(II)-catalyzed process to give the tetracyclic structure 3
when treated with PdCl2(MeCN)2 (2) and 1,4-benzoquinone 
(BQ) as reoxidant (Scheme 1, eq. 1).5e This result prompted us 
to investigate the behavior of the related N-propargyl 1-allyl-
2-indolecarboxyamide 4 towards Pd(II)-complexes in order to 
achieve reaction conditions suitable for a tandem reaction. 
When submitted to the conditions which successfully 
promoted the cyclization of 1, compound 4 was recovered 
unchanged (Scheme 1, eq. 2), while it reacted only by 
exposition to ultrasound irradiations. However, the reaction 
provided a product in 62% yield, whose analytical and 
spectroscopic data accorded to the unexpected 5-oxazole-
carbaldehyde structure 5, arising from 5-exo-dig cyclization of 
the propargylamide moiety without involving the allylindole 
portion of the starting molecule (Scheme 1, eq. 3).
SCHEME 1. Pd(II)-catalyzed oxidative cyclization of 1-allyl-2-
indolecarboxyamides 1 and 4.
From this preliminary result, we envisioned the possible 
development of a general method for producing 2-substituted 
oxazoles directly formylated in 5-position, by using 
propargylamides as starting material and working in the 
presence Pd(II)-catalysis with a reoxidant agent.
It is worthwhile to mention that the oxazole nucleus is 
present as key structural moiety in a wide number of natural 
and unnatural biologically active products,6 among which 
there are  antitumor, antiviral, and antileukemia agents, as well 
as herpes simplex virus inhibitors, serine-threonine 
phosphatase inhibitors, antibacterials, antialgicidals, and 
peripheral analgesics. Consequently, a new efficient synthesis 
of functionalized oxazoles may well be a valuable goal. Some 
protocols for the construction of the oxazole nucleus starting 
from propargylamides are already known in the literature7 and 
three of them are based on transition metal catalyzed 
cyclization (Figure 1).7g-i The first represents an effective 
access to 2,5-disubstituted oxazoles A by a tandem process 
using propargylamides and aryl iodides in the presence of 
catalytic Pd(0) species.7g The second concerns the synthesis of 
4,4-disubstituted 4H-oxazol-5-ylidenacetic acid methyl esters 
B by Pd(II)-catalyzed oxidative carbonylation.7h The third 
involves AuCl3 as catalyst affording to 5-methyl-oxazoles C.7i
Following the oxidative Pd-catalyzed process observed for 
compound 4, a new methodology to furnish directly 5-
oxazole-carbaldehydes would be desirable.
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2Figure 1. Behavior of propargylamides as tools for transition metal-
catalyzed synthesis of oxazole derivatives.
On the basis of the above considerations, we aimed to 
evaluate the generality of the envisioned reaction and first we 
tested the behaviour of the simple N-propargylbenzamide 6
under the previous successful reaction conditions. The 
experiment was accomplished by either ultrasound activation 
or heating at 60 °C and in both cases afforded the 2-phenyl-
oxazole-5-carbaldehyde (7), which was isolated in 28% and 
37% yields, respectively, beside to degradation materials 
(Scheme 2).
SCHEME 2. Palladium-catalyzed cyclization of propargylamide 
6.
The effective cyclization of the amide 6 prompted us to 
perform a number of experiments in order to improve the 
reaction yield. As summarized in Table 1, some features were 
clearly evidenced. First, palladium catalyst was essential for a 
positive outcome of the reaction. The use of an acidic catalyst, 
more specifically p-toluenesulphonic acid (PTSA) was not 
able to convert the amide 6 in any solvents (entries 3-5).8 An 
attempt to carry out the reaction by exposition of microwave 
irradiation failed because the decomposition of amide 6 was 
faster than the cyclization process (entry 6). The presence of 2
in the catalyst systems proved to be highly effective for the 
desired cyclization product (entry 2 vs entry 7). The increase 
of reaction temperature (entry 10) as well as of BQ amount 
did not improve significantly the yields (entry 11). The 
reaction was inhibited working in certain solvents or in the 
presence of a base. The use of other oxidant systems gave rise 
to different results. While MnO2 totally inhibits the conversion 
of 6 (entry 12), the environmentally friendly molecular oxygen 
showed a different behavior depending on reaction conditions. 
In particular, when combined with BQ or employed as sole 
oxidant (entries 13 and 14) it slowed the desired reaction, but 
produced 7 in highest yield when associated with CuCl2 in the 
role of co-catalyst (entry 15). The oxidative cyclization took 
place also in the presence of an excess of CuCl2 (entry 16). 
The role of CuCl2 is only of reoxidant agent and the absence 
of palladium inhibits the process.
Table 1 Optimization of the palladium catalyzed cyclization of 
propargylamide 6.
Entry Catalyst Oxidant Solventa T (°C) Yields 
of 7
1 2b BQd THF/DMF 5:3 r.t.g 28
2 2b BQd THF/DMF 5:3 60 37
3 PTSAc BQd THFc r.t. 
4 PTSAc BQd CH2Cl2 r.t. 
5 PTSAc BQd THF/DMF 5:3 r.t.g 
6 2b BQd DMF h 11
7 Pd(OAc)2c BQd THF/DMF 5:3 60 15
8 Pd(OAc)2c BQd DMF 100 18
9 2b BQd THF/DMF 5:3 r.t. 10
10 2b BQd THF/DMF 5:3 100 23
11 2c BQe THF/DMF 5:3 100 26
12 2c MnO2f THF/DMF 5:3 100 
13 2b BQ,d O2 THF/DMF 5:3i 60 29
14 2c O2 THF/DMF 5:3 100 17
15 2b CuCl2c O2 DMFj 100 46
16 2b CuCl2e DMF 100 41
17  CuCl2c O2 DMFj 100 
a
 If not differently stated, the reaction time was 3 h. b 5 mol%. c 10 
mol%. d 1 equiv. e 3 equiv. f 2 equiv. g Reactions were carried out under 
ultrasound irradiation. h Reactions were carried out under microwave 
irradiation. i 90 min. j 2 h.
Having established the optimal reaction conditions, we 
screened a series of propargylamides to generate different 2-
substituted oxazole-5-carbaldehydes. The cyclization of 
substrates 8a-j took place in higher yields working in 
conditions of entries 2 or 15 of Table 1. The better results are 
collected in Table 2. The access to the oxazole compounds 9
was accomplished on propargylamides of aromatic, 
heteroaromatic, and aliphatic carboxyacids as well as of 
natural -aminoacids. The crucial feature of this approach lies 
in its ability to access to 5-oxazole-carbaldehydes bearing an 
electron-rich heterocycles in position 2 (entries e-h). In fact, 
direct formylation of oxazoles substituted in position 2 with a 
pyrrolyl, furyl or thienyl ring provides for a competitive 
functionalization involving both the heterocyclic rings.
Despite several investigations in different reaction 
conditions, we have not in our hands a clear-cut evidence for 
determining the Pd mechanistic role. Although highly 
speculative, we propose the outcome of oxidative 
heterocyclization depicted in Scheme 3. The complexation of 
the amide 6 with Pd(II) salts takes place on the C-C triple 
bond (intermediate 10) making it susceptible of nucleophilic 
attack. The role of nucleophile is covered by the oxygen atom 
of the amide group, which gives rise to 5-exo-dig cyclization 
to produce the oxazole skeleton by formation of the -
alkenylpalladium complex 11. The intervention of water 
provided, through its enol form, the 4,5-dihydro-oxazole-5-
carbaldehyde 12, neither isolated nor detected in the reaction 
mixture (NMR). At this level the oxidizing system intervenes 
with a double role, namely i) to re-oxidize the Pd(0) species, 
formed at the end of the catalytic cycle, to the active Pd(II) 
and ii) to promote the dehydrogenation of 12 giving 7.9
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3Table 2 Cyclization yields of the propargylamides 8a-j into the 5-
oxazole-carbaldehydes 9a-j 
Entry R Condition Yield of 9
A
* OMe
 
entry 15 48
B
* NO2
entry 2 41
C
*
entry 2 54
D
*
entry 15 61
E
N
Me
*
entry 15 39
F
N
H
*
entry 15 37
G
S*
entry 15 48
H
O*
entry 15 37
I
NHBoc*
entry 15 42
J
NHBoc*
entry 15 39
In search for evidence to support the proposed mechanism, 
we applied our protocol to the ,-disubstituted 
propargylamide 13 foreseeing the impossibility of the 4,5-
dihydro-oxazole-5-carbaldehyde intermediate to undergo the 
dehydrogenation step. Accordingly, the amide 13 was 
submitted to the conditions of entries 2 and 15 (Scheme 4, 
path a). In both conditions, the 1H-NMR spectrum of the crude 
mixture revealed only signals arising from degradation of the 
starting material, plausibly because the lack of hydrogen in 4-
position of the 4,5-dihydro-oxazole precluded the oxidative 
aromatization of the putative intermediate 14. On the other 
hand, the treatment of the amide 13 with 2 (10 mol %) and 
CuCl2 (3 equiv) in DMF gave a mixture (63 % yield) of the 
compounds 15 and 16 (E/Z 6:1 ratio) (Scheme 4, path b).10
This finding indicates that the presence of chloride ions as 
potential nucleophiles warrants the formation of the stable 
vinyl chlorides 15 and 16 instead of 14.
In conclusion, the direct and effective protocol to 2-
substituted 5-oxazole-carbaldehydes described in this paper 
represents a valuable alternative to the formylation on oxazole 
rings, often unsatisfactory in term of regioselectivity and 
yields. Moreover, the protocol can be carried out by using aryl, 
heteroaryl, and alkyl propargylamides, with tolerance of 
various functional groups and sensitive heterocycles such as 
N-unsubstituted pyrrole and furan. This protocol increases the 
versatility of the propargylamides as tools in Pd-catalyzed 
reactions for the direct synthesis of oxazoles and increases the 
availability of different functionalized oxazoles accessible by 
transition metal catalysis.
SCHEME 3. Mechanism proposed for conversion of the amide 6
on the 5-oxazole-carbaldehyde 7.
SCHEME 4. Outcome of Pd(II)-catalyzed cyclization of ,-
disubstituted propargylamide 13.
Experimental Section
General procedure for the preparation of 2-substituted 
5-oxazole-carbaldehydes. Entry 2: A solution of 6 or 8a-j 
(1.0 mmol), 2 (0.05 mmol), BQ (1.0 mmol) in 8 mL of 
DMF/THF 3:5 was heated at 60 °C for 3 h. After washing 
with brine, the solution was extracted with Et2O (2 x 20 ml). 
The organic layer was dried over Na2SO4 and taken to dryness 
under reduced pressure. The crude mixture was 
chromatographed on a silica gel column giving 7 or 9a-j. 
Entry 15: A solution of CuCl2 (0.1 mmol) and 2 (0.05 mmol) 
in DMF (20 mL) was stirred at room temperature for 30 
minutes. A solution of 6 or 8a-j (1.0 mmol) in 15 mL of DMF 
was added, and then the resulting mixture was warmed at 100 
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4°C for 2 h under oxygen atmosphere. The solution was treated 
with brine and extracted with Et2O (2 x 40 ml). The organic 
layer was dried over Na2SO4 and taken to dryness under 
reduced pressure. The crude mixture was chromatographed on 
a silica gel column giving 7 or 9a-j.
2-(4-Methoxy-phenyl)-oxazole-5-carbaldehyde (9a) –
Yield: 48%. M.p. 140-142 °C (diisopropyl ether). IR (nujol): 
1680 cm-1; 1H-NMR (400 MHz, CDCl3) : 3.90 (3H, s), 7.01 
(2H, d, J = 8.8 Hz), 7.93 (1H, s), 8.13 (2H, d, J = 8.8 Hz), 
9.79 (1H, s); 13C-NMR (100 MHz, CDCl3) : 56.0 (q), 114.8 
(d), 114.9 (d), 118.8 (s), 130.1 (d), 130.5 (d), 140.1 (d), 149.7 
(s), 163.4 (s), 166.2 (s), 175.4 (d). MS: m/z 203 (M+). Anal. 
calcd for C11H9NO3: C, 65.02; H, 4.46; N, 6.89. Found C, 
64.88; H, 4.29; N, 7.16.
2-(2-Phenylethyl)-oxazole-5-carbaldehyde (9d) – Yield: 
61%. Oil; IR (nujol): 1683 cm-1; 1H-NMR (400 MHz, CDCl3) 
: 3.15-3.23 (4H, m), 7.21-7.33 (5H, m), 7.78 (1H, s), 9.74 
(1H, s); 13C-NMR (100 MHz, CDCl3) : 30.1 (t), 33.0 (t), 
126.8 (d), 128.6 (d), 129.1 (d), 138.3 (d), 139.9 (s), 150.3 (s), 
169.3 (s), 176.7 (d). MS: m/z 201 (M+). Anal. calcd for 
C12H11NO2: C, 71.63; H, 5.51; N, 6.96. Found C, 71.48; H, 
5.79; N, 7.08.
2-(2-Furyl)-oxazole-5-carbaldehyde (9h) – Yield: 37%. 
M.p. 138-140 °C (diisopropyl ether). IR (nujol): 1682 cm-1; 
1H-NMR (400 MHz, CDCl3) : 6.62-6.63 (1H, m), 7.31 (1H, 
d, J = 3.5 Hz), 7.68 (1H, s br), 7.94 (1H, s), 9.81 (1H, s); 13C-
NMR (100 MHz, CDCl3) : 113.0 (d), 116.1 (d), 139.2 (d), 
142.0 (s), 146.9 (d), 149.4 (s), 157.9 (s), 176.4 (d). MS: m/z
163 (M+). Anal. calcd for C8H5NO3: C, 58.90; H, 3.09; N, 
8.59. Found C, 59.01; H, 2.81; N, 8.35.
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